Literature DB >> 20167301

Vaccine failures after active immunisation against tick-borne encephalitis.

Charlotta Rydgård Andersson1, Sirkka Vene, Mona Insulander, Lars Lindquist, Ake Lundkvist, Göran Günther.   

Abstract

Tick-borne encephalitis (TBE) is a major disease of the central nervous system in Europe and is endemic in Sweden with about 200 notified cases annually. The far most effective protective measure against TBE is active immunisation. The vaccines available today induce a high degree of protection in field studies. However, vaccine failures have occasionally been reported and may be overlooked due to different, and sometimes confusing, antibody kinetics in vaccinees with TBEV infection. In this study, 27 patients with clinical and serological evidences of TBE despite adequate immunisation are presented. Vaccination failure is characterized by a slow, and initially non-detectable, development of the specific TBEV-IgM response, seen together with a rapid rise of IgG and neutralising antibodies in serum. The majority (70%) of the patients were more than 50 years of age, which may implicate a need for a modified immunisation strategy in the elderly. (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20167301     DOI: 10.1016/j.vaccine.2010.02.001

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  37 in total

1.  TBE--update on vaccination recommendations for children, adolescents, and adults.

Authors:  Tomas Jelinek
Journal:  Wien Med Wochenschr       Date:  2012-06-12

2.  The neurovirulence and neuroinvasiveness of chimeric tick-borne encephalitis/dengue virus can be attenuated by introducing defined mutations into the envelope and NS5 protein genes and the 3' non-coding region of the genome.

Authors:  Amber R Engel; Alexander A Rumyantsev; Olga A Maximova; James M Speicher; Brian Heiss; Brian R Murphy; Alexander G Pletnev
Journal:  Virology       Date:  2010-07-01       Impact factor: 3.616

3.  Clinical course and sequelae for tick-borne encephalitis among children in South Moravia (Czech Republic).

Authors:  Lenka Krbková; Hana Štroblová; Jana Bednářová
Journal:  Eur J Pediatr       Date:  2014-09-10       Impact factor: 3.183

4.  Tick-Borne Encephalitis Virus Nonstructural Protein 1 IgG Enzyme-Linked Immunosorbent Assay for Differentiating Infection versus Vaccination Antibody Responses.

Authors:  P Girl; M Bestehorn-Willmann; S Zange; J P Borde; G Dobler; H von Buttlar
Journal:  J Clin Microbiol       Date:  2020-03-25       Impact factor: 5.948

5.  Chimeric tick-borne encephalitis/dengue virus is attenuated in Ixodes scapularis ticks and Aedes aegypti mosquitoes.

Authors:  Amber R Engel; Dana N Mitzel; Christopher T Hanson; James B Wolfinbarger; Marshall E Bloom; Alexander G Pletnev
Journal:  Vector Borne Zoonotic Dis       Date:  2010-12-13       Impact factor: 2.133

Review 6.  Tick-borne encephalitis: A review of epidemiology, clinical characteristics, and management.

Authors:  Petra Bogovic; Franc Strle
Journal:  World J Clin Cases       Date:  2015-05-16       Impact factor: 1.337

7.  A West Nile virus DNA vaccine utilizing a modified promoter induces neutralizing antibody in younger and older healthy adults in a phase I clinical trial.

Authors:  Julie E Ledgerwood; Theodore C Pierson; Sarah A Hubka; Niraj Desai; Steve Rucker; Ingelise J Gordon; Mary E Enama; Steevenson Nelson; Martha Nason; Wenjuan Gu; Nikkida Bundrant; Richard A Koup; Robert T Bailer; John R Mascola; Gary J Nabel; Barney S Graham
Journal:  J Infect Dis       Date:  2011-03-11       Impact factor: 5.226

Review 8.  Acute viral infections of the central nervous system in immunocompetent adults: diagnosis and management.

Authors:  Marie Studahl; Lars Lindquist; Britt-Marie Eriksson; Göran Günther; Malin Bengner; Elisabeth Franzen-Röhl; Jan Fohlman; Tomas Bergström; Elisabeth Aurelius
Journal:  Drugs       Date:  2013-02       Impact factor: 9.546

9.  Dynamics and Extent of Non-Structural Protein 1-Antibody Responses in Tick-Borne Encephalitis Vaccination Breakthroughs and Unvaccinated Patients.

Authors:  Karin Stiasny; Agnes Leitner; Heidemarie Holzmann; Franz X Heinz
Journal:  Viruses       Date:  2021-05-27       Impact factor: 5.048

10.  Upregulated Intrathecal Expression of VEGF-A and Long Lasting Global Upregulation of Proinflammatory Immune Mediators in Vaccine Breakthrough Tick-Borne Encephalitis.

Authors:  Miša Pavletič; Misa Korva; Nataša Knap; Petra Bogovič; Lara Lusa; Klemen Strle; Mirijam Nahtigal Klevišar; Tomaž Vovko; Janez Tomažič; Stanka Lotrič-Furlan; Franc Strle; Tatjana Avšič-Županc
Journal:  Front Cell Infect Microbiol       Date:  2021-07-01       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.